Alto Neuroscience Inc (ANRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANRO | AZN | AMGN | GILD | BMY |
| Company | Alto Neuroscience Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 21.25 | 188.14 | 348.01 | 140.43 | 58.26 |
| High | 22.40 | 188.40 | 351.25 | 141.00 | 58.55 |
| Low | 20.57 | 184.97 | 346.51 | 138.18 | 56.98 |
| Latest | 21.82 | 186.01 | 348.70 | 138.65 | 57.56 |
| Change | -0.22 | -2.92 | -1.22 | -2.46 | -0.55 |
| % Change | -1.00% | -1.55% | -0.35% | -1.74% | -0.95% |
| Volume | 106,437 | 584,137 | 1,510,206 | 2,458,779 | 3,519,609 |
| 20-Day Average Volume | 253,697 | 1,782,191 | 2,425,068 | 6,192,018 | 12,054,130 |
| Previous Close | 22.04 | 188.93 | 349.92 | 141.11 | 58.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 21.14 | 197.03 | 371.69 | 145.73 | 60.38 |
| 20-Day Raw Stochastic | 60.70% | 3.45% | 2.75% | 3.79% | 4.95% |
| 20-Day Relative Strength | 57.78 | 40.41 | 41.69 | 44.00 | 43.74 |
| Weighted Alpha | +251.84 | +25.29 | +14.39 | +31.23 | +4.33 |
| Today's Opinion | 100% Buy | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 56% Buy | 64% Buy | 56% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.63% since 03/13/26 | -2.14% since 03/13/26 | -5.04% since 03/13/26 | -4.29% since 03/13/26 | -2.98% since 03/13/26 |
| Low | 20.57 on 03/20/26 | 184.98 on 03/20/26 | 346.51 on 03/20/26 | 138.23 on 03/20/26 | 57.03 on 03/20/26 |
| High | 25.17 on 03/17/26 | 193.96 on 03/17/26 | 370.89 on 03/16/26 | 146.71 on 03/17/26 | 60.81 on 03/17/26 |
| 1-Month | |||||
| %Chg | +25.54% since 02/20/26 | -8.99% since 02/20/26 | -7.21% since 02/20/26 | -8.34% since 02/20/26 | -5.51% since 02/20/26 |
| Low | 17.41 on 02/23/26 | 184.98 on 03/20/26 | 346.51 on 03/20/26 | 138.23 on 03/20/26 | 57.03 on 03/20/26 |
| High | 25.17 on 03/17/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 152.46 on 02/23/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +10.71% since 12/19/25 | +1.70% since 12/19/25 | +6.22% since 12/19/25 | +11.65% since 12/19/25 | +5.78% since 12/19/25 |
| Low | 13.91 on 02/06/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 25.17 on 03/17/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +514.44% since 09/19/25 | +21.81% since 09/19/25 | +21.84% since 09/19/25 | +21.63% since 09/19/25 | +27.32% since 09/19/25 |
| Low | 3.65 on 09/22/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 25.17 on 03/17/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 704,090 | 293,013,024 | 188,630,688 | 175,176,928 | 118,339,512 |
| Shares Outstanding, K | 31,946 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -61,430,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -14,180,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 2.52 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.45 on 03/16/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/13/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.57 | 16.09 | 17.34 | 9.65 |